StockData
Lantheus Holdings, Inc. logo

Lantheus Holdings, Inc. (LNTH) stock

LNTHNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3012% above fair value
$101.80+0.08 (+0.08%)

Close on Nov 17, 2026Market cap $6.64BP/E 24.6Yield –

Lantheus operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Lantheus's operating income for the twelve months ending Jun 30, 2026 was $302.34M, down 30.9% year over year. For fiscal 2025 it was $310.83M, down 32.0% from the year before. Over ten years it grew 22.0% a year on average. The highest annual figure on record is $456.98M in fiscal 2024.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$310.83M-32.0%
FY2024Dec 31, 2024$456.98M+25.3%
FY2023Dec 31, 2023$364.64M+907.4%
FY2022Dec 31, 2022$36.20M–
FY2021Dec 31, 2021-$60.83M–
FY2020Dec 31, 2020-$4.20M-108.1%
FY2019Dec 31, 2019$51.66M-19.9%
FY2018Dec 31, 2018$64.49M+24.4%
FY2017Dec 31, 2017$51.85M-8.4%
FY2016Dec 31, 2016$56.59M+33.1%
FY2015Dec 31, 2015$42.53M+7.9%
FY2014Dec 31, 2014$39.42M–
FY2013Dec 31, 2013-$18.89M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$100.22M+13.9%
Q1 FY2026Mar 31, 2026$81.33M-20.3%
Q4 FY2025Dec 31, 2025$77.18M-32.2%
Q3 FY2025Sep 30, 2025$43.62M-67.4%
Q2 FY2025Jun 30, 2025$87.97M-14.4%
Q1 FY2025Mar 31, 2025$102.07M-4.3%
Q4 FY2024Dec 31, 2024$113.87M-17.2%
Q3 FY2024Sep 30, 2024$133.74M+19.0%
Q2 FY2024Jun 30, 2024$102.73M-17.2%
Q1 FY2024Mar 31, 2024$106.64M–
Q4 FY2023Dec 31, 2023$137.49M–
Q3 FY2023Sep 30, 2023$112.36M+31.0%
Q2 FY2023Jun 30, 2023$124.14M+96.4%
Q1 FY2023Mar 31, 2023-$9.34M-115.9%
Q4 FY2022Dec 31, 2022-$171.68M–
Q3 FY2022Sep 30, 2022$85.74M–
Q2 FY2022Jun 30, 2022$63.20M–
Q1 FY2022Mar 31, 2022$58.93M+277.2%
Q4 FY2021Dec 31, 2021-$35.34M–
Q3 FY2021Sep 30, 2021-$14.33M–
Q2 FY2021Jun 30, 2021-$26.78M–
Q1 FY2021Mar 31, 2021$15.62M+119.3%
Q4 FY2020Dec 31, 2020-$528.00K-104.2%
Q3 FY2020Sep 30, 2020-$5.25M-161.6%
Q2 FY2020Jun 30, 2020-$5.55M-138.1%
Q1 FY2020Mar 31, 2020$7.13M-55.9%
Q4 FY2019Dec 31, 2019$12.44M-26.6%
Q3 FY2019Sep 30, 2019$8.52M-48.3%
Q2 FY2019Jun 30, 2019$14.54M-8.7%
Q1 FY2019Mar 31, 2019$16.17M+6.8%
Q4 FY2018Dec 31, 2018$16.94M+84.0%
Q3 FY2018Sep 30, 2018$16.48M+28.5%
Q2 FY2018Jun 30, 2018$15.93M-11.0%
Q1 FY2018Mar 31, 2018$15.14M+26.9%
Q4 FY2017Dec 31, 2017$9.21M-24.2%
Q3 FY2017Sep 30, 2017$12.82M+1.8%
Q2 FY2017Jun 30, 2017$17.90M–
Q1 FY2017Mar 31, 2017$11.93M–
Q4 FY2016Dec 31, 2016$12.14M–
Q3 FY2016Sep 30, 2016$12.60M–

More Lantheus figures

See a number that looks wrong?